Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance

Search this Article

Author(s)

    • MINAMI Hironobu
    • Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
    • OHTSU Tomoko
    • Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
    • FUJII Hirofumi
    • Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
    • IGARASHI Tadahiko
    • Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
    • ITOH Kuniaki
    • Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East
    • SASAKI Yasutsuna
    • Division of Oncology/Hematology, Department of Medicine, National Cancer Center Hospital East

Journal

  • Jpn. J. Cancer Res.

    Jpn. J. Cancer Res. 92(2), 220-230, 2001-02-28

References:  48

Cited by:  1

Codes

  • NII Article ID (NAID)
    10008060942
  • NII NACSIS-CAT ID (NCID)
    AA00690844
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    09105050
  • Data Source
    CJP  CJPref 
Page Top